Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 18
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| soleno therapeutics, inc. | 3 |
Exclusivity
Patents and exclusivities
18| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7572789 | VYKAT XRdiazoxide choline | substance, product | Dec 2026 |
| 7799777 | VYKAT XRdiazoxide choline | substance | Mar 2029 |
| 12178823 | VYKAT XRdiazoxide choline | use | Nov 2035 |
| 12343348 | VYKAT XRdiazoxide choline | use | Nov 2035 |
| 12419895 | VYKAT XRdiazoxide choline | use | Nov 2035 |
| 9757384 | VYKAT XRdiazoxide choline | use | Nov 2035 |
| Product | Exclusivity | Until |
|---|---|---|
| VYKAT XRDIAZOXIDE CHOLINE | ODE-532 Orphan drug | Mar 2032 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| VYKAT XR | diazoxide choline | tablet, film coated, oral | 83860-025NDA |
| VYKAT XR | diazoxide choline | tablet, film coated, oral | 83860-075NDA |
| VYKAT XR | diazoxide choline | tablet, film coated, oral | 83860-150NDA |
Enquiry
Common questions
- Is Soleno Therapeutics, Inc. FDA approved?
- Soleno Therapeutics, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Soleno Therapeutics, Inc. make?
- 3 products are listed under Soleno Therapeutics, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.